Background: Nocturnal airway narrowing is a common characteristic of asthma that remains poorly understood. Sleep itself or rapid eye movement (REM) sleep has been suspected to play a role in the etiology of nocturnal asthma; however, only inconsistent findings have so far been produced. The purpose of this study was to examine the effect of sleep deprivation, particularly REM sleep, using the classical platform (flowerpot) method on asthmatic responses in a rat model of asthma, in a situation of immobilization stress. Methods: After the rats had been randomly divided into three groups of 9 including (1) a caged control group, (2) a large (sham) platform group, and (3) a small platform group, we investigated the effect of REM sleep deprivation over a 72-hour period on both the antigen-induced immediate asthmatic response (IAR) and late asthmatic response (LAR) including the changes of stress hormones. Results: The small platform group showed significantly lower plasma histamine levels and higher plasma adrenaline levels during the IAR compared to the control group (p < 0.05). The number of eosinophils in either the bronchoalveolar lavage fluid or the bronchial lamina propria during the LAR in the small platform group was reliably suppressed compared to the other groups (p < 0.05). No significant differences were found in the plasma corticosterone and noradrenaline levels among the three groups, irrespective of the phase of the asthmatic response. Conclusions: Our results indicate that REM sleep contributes to nocturnal asthma, possibly due to an alteration of the sympathetic nervous function.

1.
Barnes P, Fitzgerald G, Brown M, Dollery C: Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med 1980;303:263–267.
2.
Cochrane GM, Clark TJH: A survey of asthma mortality in patients between ages 35 and 64 in the Greater London Hospitals. Thorax 1975;30:300–305.
3.
Barnes PJ: Nocturnal asthma. Practitioner 1987;231:479–481.
4.
Ballard RD: Sleep, respiratory physiology, and nocturnal asthma. Chronobiol Int 1999;16:565–580.
5.
Catterall JR, Rhind GB, Stewart IC, Whyte KF, Shapiro CM, Douglas NJ: Effect of sleep deprivation on overnight bronchoconstriction in nocturnal asthma. Thorax 1986;41:676–680.
6.
Ballard RD, Saathoff MC, Patel DK, Kelly PL, Martin RJ: Effect of sleep on nocturnal bronchoconstriction and ventilatory patterns in asthmatics. J Appl Physiol 1989;67:243–249.
7.
Kales A, Kales JD, Sjy RM, Scharf MB, Tjiauw-Ling T, Preston TA: Sleep patterns of asthmatic children; all-night electroencephalographic studies. J Allergy 1970;6:300–308.
8.
Montplaisir J, Walsh J, Malo JL: Nocturnal asthma; features of attacks, sleep and breathing patterns. Am Rev Respir Dis 1982;125:18–22.
9.
Ravenscroft K Jr, Hartman EL: The temporal correlations of nocturnal asthmatic attacks and D-state. Psychophysiology 1968;4:396–397.
10.
Shapiro CM, Catterall JR, Montgomery I, Raab GM, Douglas NJ: Do asthmatics suffer bronchoconstriction during rapid eye movement sleep? Br Med J 1986;292:1161–1164.
11.
Tabachnik E, Muller NL, Levinson H, Bryan AC: Chest wall mechanics and pattern of breathing during sleep in asthmatic adolescents. Am Rev Respir Dis 1981;124:269–273.
12.
Issa FQ, Sullivan CE: Respiratory muscle activity and thoracoabdominal motion during acute episodes of asthma during sleep. Am Rev Respir Dis 1985;132:999–1004.
13.
Bellia V, Cuttitta G, Insalaco G, Visconti A, Bonsignore G: Relationship of nocturnal bronchoconstriction to sleep stages. Am Rev Respir Dis 1989;140:363–367.
14.
Stern WC: Acquisition impairments following rapid eye movement sleep deprivation in rats. Physiol Behav 1971;7:345–352.
15.
Hicks RA, Moore JD: REM sleep deprivation diminishes fear in rats. Physiol Behav 1979;22:689–692.
16.
Murison R, Ursin R, Coover GD, Lien W, Ursin H: Sleep deprivation procedure produces stomach lesions in rats. Physiol Behav 1982;29:693–694.
17.
Nakano H, Kubo C, Sogawa H, Teshima H, Nakagawa T: Effect of REM sleep deprivation on immune function in rats. Med Sci Res 1992;20:65–66.
18.
Barnes PJ: Inflammatory mechanisms and nocturnal asthma. Am J Med 1988;85:64–70.
19.
Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651–663.
20.
Bates ME, Clayton M, Calhoun W, Jarjour N, Schrader L, Geiger K, Schultz T, Sedgwick J, Swenson C, Busse W: Relationship of plasma epinephrine and circulating eosinophils to nocturnal asthma. Am J Respir Crit Care Med 1994;149:667–672.
21.
Martin RJ, Cicutto LC, Smith HR, Ballard RD, Szefler SJ: Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991;143:351–357.
22.
Skoner DP, Page R, Asman B, Gillen L, Fireman P: Plasma elevations of histamine and a prostaglandin metabolite in acute asthma. Am Rev Respir Dis 1988;137:1009–1014.
23.
Bousquet J, Chanez P, Lacoste JY, Barnéon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Francois-Bernard M: Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033–1039.
24.
Eidelman DH, Bellofiore S, Martin JG: Late airway responses to antigen challenge in sensitized inbred rats. Am Rev Respir Dis 1988;137:1033–1037.
25.
McBride P, Bradley D, Kaliner M: Evaluation of a radioimmunoassay for histamine measurement in biologic fluids. J Allergy Clin Immunol 1988;82:638–646.
26.
Orem J, Netick A, Dement WC: Increased upper airway resistance to breathing during sleep in the cat. Electroencephalogr Clin Neurophysiol 1977;43:14–22.
27.
Sullivan CE, Zamel N, Kozar LF, Murphy E, Phillipson EA: Regulation of airway smooth muscle tone in sleeping dogs. Am Rev Respir Dis 1979;119:87–99.
28.
Reed CE, Cohen M, Enta T: Reduced effect of epinephrine on circulating eosinophils in asthma and after beta-adrenergic blockade or Bordetella pertussis vaccine. With a note on eosinopenia after methacholine. J Allergy 1970;46:90–102.
29.
Sabag N, Castrillön MA, Tchernitchin A: Cortisol-induced migration of eosinophil leukocytes to lymphoid organs. Experientia 1978;34:666–667.
30.
Schleimer RP, Lichtenstein LM, Gillespie E: Inhibition of basophil histamine release by anti-inflammatory steroids. Nature 1981;292:454–455.
31.
Alm PE, Bloom GD: Catecholamine inhibition of rat mast cell histamine secretion – A process independent of cyclic AMP levels and counteracted by glucose. Life Sci 1983;32:307–314.
32.
Porkka-Heiskanen T, Smith SE, Taira T, Urban JH, Levine JE, Turek FW, Stenberg D: Noradrenergic activity in rat brain during rapid eye movement sleep deprivation and rebound sleep. Am J Physiol 1995;268:R1456–R1463.
33.
Prinz PN, Halter J, Benedetti C, Raskind M: Circadian variation of plasma catecholamines in young and old men: Relation to rapid eye movement and slow wave sleep. J Clin Endocrinol Metab 1979;49:300–304.
34.
Dodt C, Breckling U, Derad I, Fehm HL, Born J: Plasma adrenaline and noradrenaline concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1997;30/1:71–76.
35.
Ida Y, Tanaka M, Tsuda A, Tsujimaru S, Nagasaki N: Attenuating effect of diazepam on stress-induced increases in noradrenaline turnover in specific brain regions of rats: Antagonism by Ro 15-1788. Life Sci 1985;37:2491–2498.
36.
Read NW: Irritable bowel syndrome (IBS) – Definition and pathophysiology. Scand J Gastroenterol 1987;130(suppl):7–13.
37.
Rossman L: Defecation-induced bronchospasm. J Emerg Med 2000;18:195–197.
38.
Anderson SD, Holzer K: Exercise-induced asthma: Is it the right diagnosis in elite athletes? J Allergy Clin Immunol 2000;106:419–428.
39.
Moloney E, O’Sullivan S, Hogan T, Poulter LW, Burke CM: Airway dehydration: A therapeutic target in asthma? Chest 2002;121:1806–1811.
40.
Eggleston PA, Kagey-Sobotka A, Lichtenstein LM: A comparison of the osmotic activation of basophils and human lung mast cells. Am Rev Respir Dis 1987;135:1043–1048.
41.
Anderson SD, Daviskas E, Smith CM: Exercise-induced asthma: A difference in opinion regarding the stimulus. Allergy Proc 1989;10:215–216.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.